Golub Capital BDC, Inc. (GBDC) Earnings Call Transcript & Summary

December 1, 2020

NASDAQ US Financials Capital Markets earnings 40 min

Earnings Call Speaker Segments

David Golub

executive
#1

Appreciate that, Alicia. Hi everyone, and thank you for being with us today. Alongside me are Ross Teune, who serves as our Chief Financial Officer, plus Greg Robbins and Jon Simmons, both of whom are Managing Directors at Golub Capital. Everyone here at Golub Capital hopes you and your loved ones are doing well and that, same as us, you're bouncing back from overindulging at Thanksgiving. Yesterday afternoon we put out our earnings press release covering the quarter and fiscal year that closed on September 30th, and we also posted an earnings presentation on our website. We'll be referencing that presentation at various points during today's call. For those of you who are just getting acquainted with GBDC, the way we invest — and this has been true since day one — centers on providing first lien senior secured loans to middle market companies that are healthy and resilient, and that have strong, partnership oriented private equity sponsors standing behind them. Let me begin today's meeting with a few headlines: the first headline is that GBDC's fiscal Q4 results came in strong and matched the preliminary estimates we filed on October 19th. These results were driven mainly by the ongoing continuation of the trends we laid out on last quarter's earnings call, and I'll get into those trends shortly. Headline number two is that GBDC sits in a very well-positioned spot as we move into fiscal 2021, with plenty of dry powder, liquidity, and flexibility to take advantage of what we anticipate will be an attractive investment environment in fiscal 2021. I'll go deeper on this during my closing remarks, and afterward we'll open things up for your questions. Let's now dig into GBDC's results for the quarter and the fiscal year, along with the key drivers behind them. Please flip to slide four; for fiscal Q4, GBDC's adjusted net investment income per share came to $0.28, adjusted EPS was $0.57, and ending NAV per share stood at $14.33. Each of these landed at the midpoint of the guidance we'd published earlier. As I mentioned, what primarily drove these results was the ongoing continuation of trends we discussed last quarter. What exactly does that mean? Slide six lays out three key themes — beyond just straightforward good underwriting — that we believe propelled GBDC's strong fiscal fourth quarter. First, during calendar Q3, the U.S. economy staged a strong rebound from the heavy degree of COVID impact felt in calendar Q2. Second, our portfolio companies by and large kept performing better than anticipated, particularly those sitting in COVID impacted sub sectors; and third, private equity sponsors have by and large kept stepping up to support their portfolio companies. Themes two and three probably sound familiar, and that's expected. This quarter's results mostly kept building on the previous quarter's story, and just like in fiscal Q3, you can see those themes reflected in the favorable credit quality shifts shown on the right side of this slide. So let's walk through each metric on that slide, starting with performance ratings. Please turn to slide seven, where internal performance ratings continued to improve throughout fiscal Q4. Before we go further, some context helps. You might recall that when we presented last quarter's earnings, we highlighted how internal performance ratings had moved upward during fiscal Q3. We saw growth in the fourth and fifth loan categories — these represent loans doing at least as well as we anticipated when we underwrote them. Meanwhile, category three loans went down. Those are loans that are performing, or we expect will perform, worse than we'd projected. The portion of the portfolio doing notably worse than expected — categories one and two — dropped considerably as well between fiscal Q2 and fiscal Q3. All of these positive patterns continued through fiscal Q4. In fiscal Q4, loans in categories four and five continued to climb; they went from making up 76% of the portfolio on 6/30 to 78.9% of it on 9/30. Loans in category three continued to decline, going from 22.3% on 6/30 down to 19.7% on 9/30; similarly, category one and two loans decreased versus the prior quarter, from 1.7% to 1.4%. That tiny portion of the book in categories one and two strikes me as particularly meaningful, because it demonstrates that even under COVID stress, meaningful credit damage within the portfolio is still uncommon and isolated. The percentage of the portfolio marked as three remains higher than what we generally observed before COVID, yet it has gotten considerably better since 3/31 and continues trending favorably. Non-accruals serve as the second important signal of improved credit quality. Non-accruals at fair value also declined, dropping from 2% on June 30 to 1.7%. We're going to come back to that topic when we do our standard review of GBDC's financial results. On slide eight, you can see two additional important measures that point to stronger credit quality: minimal net realized losses and healthy net unrealized gains. This slide therefore presents a bridge from GBDC's net asset value per share of $14.05 on 6/30 to $14.33 per share on 9/30. Let's move through that bridge quickly. Adjusted net investment income per share came to $0.28, which matched our dividend of $0.29 cents and was consistent with the quarter before. Net realized losses were quite low, at $0.02 per share, while net unrealized gains reached $0.36 per share. The gains we haven't cashed in yet came from writing back more of the paper losses we took during the March quarter. As I've mentioned in the past, ever since COVID hit, our number one goal — and it still is — has been holding GBDC's permanent, meaning realized, credit losses down as much as possible. If you look at the big picture, paper gains and paper losses even out over time; for a lender such as ourselves, one that generally keeps loans until they mature, the only thing that truly counts is whether borrowers pay those loans back. That's why we're happy to share that GBDC held realized credit losses at a low level during fiscal Q4 while also benefiting from yet another sizable reversal of unrealized losses. Okay, I'll now pass things along to Greg Robbins, who will share where we stand on our strategy for addressing COVID-19.

Gregory Robbins

executive
#2

Thanks, David. If you turn to slide 10, it's clear that GBDC keeps delivering against the three main objectives it set for steering through the COVID-19 crisis. The first is staying proactive in how we manage a portfolio that's heavily diversified and made up of first lien senior secured investments. The second is continuing to make our balance sheet as efficient as possible. And the third is seizing appealing chances to put money into new investments. Now if you look at slide 11, you may remember how we laid out a strategy with three phases for actively handling our portfolio through COVID-19. That meant collecting information, putting together strategic plans, and then carrying out those plans; at this point we've reached phase three, and for every borrower that's been impacted, we've been rolling out tailored game plans, collaborating closely with sponsors, management teams, and lenders providing junior capital. This approach has delivered significant results. Our team has completed over 90 amendments that enhance credit; by that we mean an amendment that includes a wider spread, better terms in the documentation, or an additional injection of equity; we've spoken extensively about how strongly sponsors have backed the companies in our portfolio. Let me give you one example of what that looks like. From the time COVID started, sponsors have injected more than $700 million in fresh equity into companies within the GBDC portfolio. Slide 12 illustrates the way GBDC strengthened its balance sheet as of September 30th. On a GAAP basis, leverage stood at 0.85 times, placing it at the bottom of our target range. When it comes to regulatory leverage, the figure was 0.76 times. At the close of the quarter, GBDC held close to $500 million in liquidity, consisting of cash along with available borrowing capacity. We've also kept working to make GBDC's debt capital structure more efficient. Over the quarter, GBDC finished its fourth CLO, which is flexible and comes at a low cost. We're still among just a few BDCs that have steady entry to this funding market on favorable terms, even with COVID in the picture. And as of September 30th, GBDC earned investment-grade ratings from both S&P and Fitch, and set the price on its first-ever issuance of $400 million in unsecured bonds. Those bonds carry an interest rate of 3.375%, making it one of the cheapest debut unsecured bond issuances ever done in the BDC sector. GBDC directed the proceeds mainly toward paying down secured debt held under revolving credit facilities, which has greatly enlarged GBDC's base of unencumbered assets while not meaningfully altering GBDC's leverage overall. Thanks to these moves, GBDC now has greater flexibility and more firepower. That added flexibility and firepower leave GBDC well positioned to take advantage of appealing opportunities. And just as we've talked about in earlier quarters and shown on slide 13, we think GBDC holds strong competitive edges that will assist us in producing superior shareholder returns down the road. With that said, I'll pass things to Jon Simmons so he can walk through our financial results for the quarter that ended September 30 in greater depth. Jon?

Jon Simmons

executive
#3

Appreciate that, Gregory. So as a quick note, besides the GAAP figures shown in the investor presentation, we are also presenting some non-GAAP figures. Those non-GAAP figures we call adjusted measures, and their purpose is to remove the effect of the GCIC merger-related purchase premium write-off and amortization; additional details on those adjusted measures appear in the appendix of the earnings presentation. We will use them where suitable since we believe they give a clearer picture of how we are performing and line up with the way we assess our own results. With that said, let's move to slide 15, and I'll walk through the column on the right hand side of the page to cover the quarter in greater depth. Adjusted net investment income per share, which we also call income before credit losses, came in at $0.28 for the quarter ending September 30th. Adjusted net realized and unrealized gain per share came in at $0.29. That is compared with an adjusted net realized and unrealized gain per share of $0.66 for the quarter ending June 30th. The adjusted net realized and unrealized gain in this quarter was mainly the result of the ongoing reversal of unrealized losses from the March quarter. Adjusted earnings per share for the quarter that ended September 30th came in at $0.57. That is compared with adjusted earnings per share of $0.94 for the quarter ending June 30th. Our net asset value per share on September 30th, 2020 rose to $14.33, an increase from $14.05 on June 30th. On September 29th, we made a quarterly distribution payment of $0.29 per share. And last, on November 20th, 2020, our Board declared a quarterly distribution of $0.29 per share, payable on December 30th, 2020, to shareholders of record on December 11, 2020. This distribution aligns with our historical cash distributions, which come to roughly 8% of NAV each year; with that, I'll pass the call to Ross so he can walk through the quarterly results in greater detail. Ross?

Ross Teune

executive
#4

Thanks a lot, Jon. Now if we look at slide 16, you'll see that for the quarter that closed on September 30th — apologies, I first said June 30th — our total originations came to $141.2 million, while total exits and sales of investments reached $172.4 million. During last quarter's earnings call, we mentioned that deal activity had begun to pick up, and that momentum has carried over into this quarter. When you factor in unrealized appreciation along with other portfolio activity, total investments at fair value were down modestly, by 0.3%, which works out to 12.2 million. As of September 30th, undrawn revolver commitments stand at $41.6 million, and undrawn commitments on delayed draw term loans stand at $100.2 million; when you consider GBDC's balance sheet and liquidity position, these unfunded commitments are fairly small. The table at the bottom shows that the weighted average rate on new investments was 7.6%, and the weighted average spread over LIBOR on new floating rate investments was 6.5% — both figures rose compared with the prior quarter. Just as a reminder, the weighted average interest rate on new investments is calculated using the contractual interest rate at the time of funding; when it comes to variable rate loans, that contractual rate would be figured using current LIBOR, the spread over LIBOR, and whatever impact a LIBOR floor has. At the top of slide 17, you can see that GBDC's portfolio stayed highly diversified by obligor, with an average investment size under 40 basis points. The bottom portion of that slide shows that our overall portfolio mix by investment type stayed consistent from one quarter to the next, and one stop loans remain our biggest investment category, at 82% of the portfolio. Moving to slide 18, 97% of our investment portfolio was still in first lien secured floating rate loans, defensively positioned in industries we consider resilient. One thing worth mentioning is that we updated our industry classification this quarter, adopting the S&P 2018 industry codes. In our view, this change gives investors greater detail and transparency regarding the industry exposure of our underlying portfolio compared with the industry classifications we had been using before. Now on slide 19, this graph sums up portfolio yields and net investment spreads for the quarter. Let's start with the light blue line, which represents the income yield — that is, the actual amount earned on the investments, including interest and fee income, but not counting the amortization of upfront origination fees and purchase price premium. The income yield fell by 30 basis points, to 7.4% for the quarter, mainly because LIBOR kept declining. The investment income yield, shown by the dark blue line, which does include the amortization of fees and discounts, likewise dropped by 30 basis points, to 7.8% during the quarter, again mainly due to LIBOR's decline. Because our variable rate debt facilities have no LIBOR floor, our weighted average cost of debt, the aqua blue line, went down by 50 basis points, to 2.7%. So because of that, our net investment spread—that's the green line, representing the gap between what we earn on investment income yield and the weighted average cost of debt—went up 20 basis points, reaching 5.1%. Moving ahead to the following two slides, non-accrual investments measured as a percentage of total debt investments at cost and fair value stayed low, dropping to 2.4% and 1.7%, respectively, as of September 30th. Over the quarter, non-accrual investments fell in number to nine, since one portfolio company investment got restructured and went back to accrual status. As David said during his opening commentary, thanks to stronger performance from portfolio companies, the share of investments rated three on our internal performance rating scale dropped to 19.7% of the portfolio at fair value as of September 30th. Just a reminder, independent valuation firms assess no less than 25% of our investments every quarter. Slides 22 and 23 offer more specifics on our balance sheet and income statement as of and for the three months ended September 30. On slide 24, the top graph gives a summary of our quarterly returns on equity across the last five years, while the bottom one summarizes our regular quarterly distributions plus our special distributions during that same period. Moving to slide 25, this graph shows our lengthy track record of solid shareholder returns from our IPO onward. Slide 26 gives a summary of our liquidity and investment capacity as of September 30th, and points out recent steps taken to further strengthen the right side of our balance sheet. As Gregory noted, over the quarter we issued $189 million in notes via a term debt securitization on August 26. Those proceeds went toward redeeming all outstanding notes from the 2014 debt securitization along with outstanding debentures issued by one of our SBIC subsidiaries, GC SBIC IV. We additionally issued $400 million in unsecured notes on October 2nd, using the proceeds to pay down existing debt, which included fully repaying the revolving credit facility with Deutsche Bank. Slide 27 lays out the terms of our debt facilities as of September 30th, before the bond deal closed on October 2; and finally, slide 28 gives a summary of our lengthy record of consistent distributions. Most recently, our Board declared a distribution of $0.29 per share payable on December 30th to stockholders of record as of December 11th. With that, I'll hand it over — hand it back to David for some closing remarks.

David Golub

executive
#5

Appreciate it, Ross. So, in summary, GBDC delivered a solid fiscal Q4. Adjusted net investment income came in steady, realized credit losses stayed quite minimal, and unrealized gains were sizable, which mirrors the ongoing reversal of unrealized losses that we took in the March quarter. During my opening remarks, I noted that in our view GBDC sits in a good position. Let me now go into detail about the reasons we believe that holds true. Number one, credit. Our view is that the portfolio is well diversified, set up defensively, and we expect to record additional reversals of unrealized losses in the quarters ahead. Number two, available capital and balance sheet flexibility. GAAP leverage for the company sits at a modest 0.85 times debt-to-equity, which falls short of our target. We have plenty of liquidity, and our capital base is both solid and adaptable. Number three, the deal environment. M&A activity is currently quiet owing to uncertainty tied to COVID, yet our expectation is that during 2021 the landscape will get better and private equity firms will speed up how quickly they put money to work. Keep in mind that private equity is sitting on the biggest stockpile of dry powder it has ever had; Preqin's data puts it above $1.5 trillion. For some perspective, the entire syndicated loan market today amounts to $1 trillion. Therefore, in our view, private equity's ongoing expansion is practically assured and amounts to a significant tailwind for sponsor finance businesses such as ours. Number four, competitive advantages. In meaningful respects, this stretch affected by COVID has actually been letting our strengths shine. Building new relationships is tough; forging deep connections over Zoom is tough. As a result, sponsors naturally lean toward working with lenders they're already familiar with; for us that has proved quite beneficial since we hold plenty of excellent relationships already. As I've previously shared with this group, over 80% of what we originate annually, stretching back close to 10 years, has come from a core set of roughly 200 sponsors with whom we've closed multiple transactions. The story around incumbencies looks much the same. Before COVID, the lender already in place usually held the pole position whenever a company required additional capital or was being sold by one sponsor to another. After COVID, we believe this is holding even truer for the reasons I just described. Once again, it comes down to — how hard it is to switch versus conducting due diligence and building new relationships over zoom. Each of these factors magnifies the competitive edges enjoyed by bigger, established lenders such as Golub Capital. Our remaining competitive advantages matter too, among them our substantial buy and hold capabilities, our track record for dependability, our market leadership in one stops, our extensive industry knowledge, our capacity to partner with sponsors across a broad array of transaction types: large or small, traditional senior or one stops, buy and hold or syndicated; which explains why our game plan for fiscal 2021 will sound quite familiar. It is to stay humble and cautious and rely on these competitive advantages that have treated us well. Thank you. Operator, please open the line for questions.

Robert Dodd

analyst
#6

Hello everyone, and well done on the quarter across several dimensions. Let me start with a procedural question, if I may: once the Deutsche Bank facility was terminated following your unsecured notes issuance, should we expect any acceleration or accelerated expenses associated with that in the coming quarter?

David Golub

executive
#7

Ross, I'll have you take that one.

Ross Teune

executive
#8

No, Robert, there was nothing significant.

Robert Dodd

analyst
#9

Understood, thanks. Now, David, regarding one remark you made toward the end — that you believe the portfolio is positioned for further unrealized gains? If I examine the numbers, there's roughly a dollar per share of depreciation remaining, based on where fair value sits relative to cost today. What makes you confident you'll recover something above that? Does it stem from the partial recovery you've already seen, and is that connected directly to the extra $700 million in sponsor equity — the 700 — that sponsors contributed? When you talk about that appreciation—the gains you expect down the road—does it hinge on private equity stepping up with additional capital, or is something else behind your belief that you'll recover more of it?

David Golub

executive
#10

Absolutely. Let me take you back and frame the situation. As of March 31, the write-downs we recorded came from a combination of things. First, there was some spread widening—broad market spread widening tied to uncertainty around COVID. Second, we anticipated that the lockdowns and the effects of COVID would hurt credit, independent of what was happening with spreads. When we look at these two, separating one from the other is difficult. There were really two main factors at play. The first had to do with spreads, and the second had to do with credit. So here we are roughly nine months afterward, and we now possess far more knowledge regarding COVID's likely effects and how businesses would end up performing than what was available to the market back then. And a couple of developments have taken place. First, spreads have tightened, since markets in general have bounced back substantially since March. Second, when it comes specifically to our own portfolio, results have come in above what we anticipated; and back when we discussed the quarter ending June 30th, we noted performance that was considerably stronger than expected. I mentioned this once more when we discussed the quarter that closed on September 30th. What's behind the stronger results we've been seeing? There isn't just one explanation. Solid underwriting is one factor. Another is that leadership teams have proven highly capable of adapting—trimming expenses, uncovering fresh streams of revenue, and steering their businesses toward substantial profitability and healthy cash generation even when conditions are tough. A third factor, which you touched on, involves sponsors rising to the occasion; their backing has been quite substantial, whether through guidance and advice, through operating executives brought in from outside, or through injections of equity. Separating out how much of the valuation improvement and unrealized gains comes from each of those specific threads I just walked through strikes me as a difficult exercise. What's encouraging, Robert, is that every one of them continues to carry substantial momentum. How should I frame it? Basically, the economy keeps beating what I had expected, management teams keep surpassing our forecasts, and sponsors stay very much in our corner. So the basis for my optimism isn't one isolated factor — it's the entire collection of them. Still, I don't want anyone to hear this as a commitment of some kind. A commitment it is not. Whether we look at investors or just at people in general, everyone right now confronts a great many things that are uncertain. COVID hasn't been cured. No vaccine has been broadly distributed yet. Various possible risk sources exist. Still, sitting here in November — December 1, rather, my apologies — I'd say I feel cautiously optimistic about our capacity to keep managing the portfolio so realized losses stay low while some unrealized gains carry on building.

David Golub

executive
#11

Robert, thanks for that. Sure, I can take one more quick one. When it comes to your remarks, it sounded as though your outlook for 2021 is far more upbeat than where things stand right now — December is here, and only one month remains in the year. So what exactly is the activity level doing? Obviously, my sense is that things began picking up as we moved into this fourth calendar quarter. What are you actually observing on the activity front, or — when you describe the M&A market as muted, does that refer to closings? Does it refer to activity? Is it simply that people aren't rushing at this point and feel less concerned about taxes shifting next year or anything along those lines? Is there something specific happening during this year, or is it more that things are simply pushing into the next year?

David Golub

executive
#12

Well, once more, to frame it properly: during calendar Q2, activity was extremely low since everyone was reacting to the shock of COVID, and new deal activity was scarce everywhere, including in areas that COVID affected less. Then, in calendar Q3, a partial recovery began to emerge, especially in sectors less harmed by COVID, such as software and certain parts of healthcare. As today's reported results show, new originations were substantially greater in the quarter that closed September 30th compared with the one that closed June 30th. I expect the trend we saw to carry over into the quarter that closed on December 31st. Improvement will keep coming, and when we look at calendar Q4 versus calendar Q3, the number of originations should come in higher. That pattern shows up across the board, too. Put differently, it isn't limited to software plus a handful of healthcare niches — the reach is wider. Still, holding calendar Q4 2020 next to calendar Q4 2019, the 2020 period looks subdued by comparison. My sense is we won't begin to record year-over-year gains in M&A activity and new originations until we get into 2021. One thing will drive this, and it's quite straightforward: less uncertainty surrounding COVID.

Robert Dodd

analyst
#13

Got it. Thanks.

Ryan Lynch

analyst
#14

Hi there, good morning, and thanks for fielding my questions. The first thing I hoped to ask about — you said there was a single default during the quarter along with a restructuring. Did that involve Rubio Restaurants, or which portfolio company was it tied to?

David Golub

executive
#15

Rubio's is a default — the business is in bankruptcy right now, and together with the company and its sponsor we're working on a restructuring so it can come out of bankruptcy and perform well once more. I'd say it's a company that's in good shape to pull that off. The other business I believe you're referring to, which happened in calendar Q3, is a dental practice company named Elite Dental, where we likewise completed a consensual restructuring, and through that we lowered the debt load on the company and acquired an equity stake.

Ryan Lynch

analyst
#16

All right, that's great. You brought this up a bit ago, and it also came through in your presentation — since COVID, you've completed more than 90 amendments that improve credit quality, targeting certain sub sectors that took the hardest hit from COVID-19. Speaking more broadly, whenever you're considering a credit amendment for a company — and I realize no two cases are alike — could you perhaps take us through the sorts of priorities you weigh? Is the aim to secure wider spreads, additional fees, stricter protections on your covenants, and what do you want most in exchange from the private equity sponsors who back those amendments?

David Golub

executive
#17

Generalizing is tough — I believe your setup and your question are correct; a single answer to that is difficult to provide. Our top objective, and I think I've made this quite plain, our top objective is keeping realized credit losses as low as possible. So if you ranked what matters to us, the number one and most significant item for us is helping us steer clear of losing money. Past that, it's heavily dependent on the specific situation, and we examine every fact and circumstance for a given borrower and determine what carries the most weight for us and what carries the most weight for the sponsor and the company, and try to build a win-win outcome.

Ryan Lynch

analyst
#18

Alright, thanks. I've got one last thing to ask regarding those unsecured notes you issued. To start, nice work on getting the investment-grade rating and completing that offering — the coupon you secured was really strong. As things stand right now, your balance sheet appears quite healthy, with leverage staying quite low. There's also solid diversification at present, though when I look ahead, unsecured notes seem to make up roughly 20% of your liability structure. Do you intend to keep it around that figure moving forward, or would you prefer to push it higher? Or could it be more of a case-by-case thing — whenever a new market becomes available with really appealing rates, you'd consider going to the unsecured market to raise additional funds?

David Golub

executive
#19

I'd put it at roughly two to three. So the answer is yes, eventually we want unsecured notes to make up a larger share of our debt, and yes, we'll be selective and deliberate about timing our market visits, since we view our liabilities as a key competitive edge and consider them among the most important items we can oversee.

Ryan Lynch

analyst
#20

All right, that's everything from my side. Thanks for making time today.

John Kemmerer

analyst
#21

Hello there. John here. My question follows up on what the Fed said yesterday regarding the LIBOR phase-out. I'm just wondering, when do you expect we'll see the first loan of yours using a benchmark other than LIBOR? And a somewhat connected question — could you perhaps give me a rundown of how this change affects your operations overall?

David Golub

executive
#22

Absolutely. So, as just about everyone listening probably already knows, there's a push across the industry to move away from LIBOR toward a new benchmark for floating rate loans called SOFR; we sit on the LSTA, which is the trade group for the Loan Syndication Trading Association, specifically its special committee on LIBOR transition, and we expect that the shift from LIBOR to SOFR won't be especially dramatic. On our end, several working groups are in place to ensure we've got the right systems and operational procedures ready for the change. I'd say that's well under control. To me, it's somewhat comparable to Y2K — it takes a great deal of effort beforehand, and then once it arrives, you nearly forget such a deal, since all the prep, work, and anticipation turned it into a non-event. So, right now we're in that stage of working and preparing.

John Kemmerer

analyst
#23

Understood. Is there a schedule for when the initial loan using the new benchmark could be originated?

David Golub

executive
#24

Well, I believe the loans will include LIBOR wording together with what is referred to as fallback language — in other words, a defined provision indicating what takes effect once LIBOR goes away. And that's beginning to appear — every bit of that inside credit agreements at this point.

John Kemmerer

analyst
#25

All right, thanks.

David Golub

executive
#26

Wonderful. So, once more I'd like to express my appreciation to everybody for joining us on this quarter's call. I'm eager to talk with all of you again next quarter. And, as ever, should anything come up before that point, don't hesitate to reach out to any one of us.

Operator

operator
#27

That brings today's conference call to a close. We appreciate everyone taking part, and we ask that you now disconnect your line.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Golub Capital BDC, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Golub Capital BDC, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Golub Capital BDC, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.